Pro-Dex, Inc. PDEX
Set alert
58.16 USD -3.44 -5.58%
At close · Oct 30
58.16 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
58.00 Day range 65.65
28.91 52-week range 73.41
- YTD
- +51.14%
- 1 year
- +89.88%
- Open
- 65.65
- Prev close
- 61.60
- Mkt cap
- 188.04M
- Vol
- 38.49K
- Avg vol
- 64.19K
- EPS
- 4.12
- P/E
- 14.12
- Div yield
- 0.00%
More statistics
- Low
- 58.00
- High
- 65.65
- Forward P/E
- 22.28
- Beta
- 0.39
- Short ratio
- 0.44
- Inst. own
- 27.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 41.69
- 200-d avg
- 25.75
- 1y target
- 52.00
Key statistics
- Market cap
- 149.60M
- Enterprise value
- 166.05M
- Trailing P/E
- 30.20
- Forward P/E
- 22.28
- PEG ratio
- 0.00
- Price / sales
- 2.63
- Price / book
- 4.90
- EPS (TTM)
- 1.52
- Beta
- 0.39
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 9.17%
- Revenue (TTM)
- 56.80M
- Revenue growth
- 24.70%
- Free cash flow
- 6.52M
- Total cash
- 7.82M
- Total debt
- 15.01M
- Return on equity
- 16.78%
- Shares outstanding
- 3.26M
- Short % of float
- 7.29%
- 50-day average
- 41.69
- 200-day average
- 25.75
Analyst view
Consensus: none
Price target (mean) 52.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 13, 2025
Expected Feb 13, 2025. Consensus EPS estimate 0.38.
Financials — quick view
PDEX Revenue — quarterly 20.56M
PDEX Net income — quarterly 3.05M
PDEX EPS — quarterly 0.95
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2025 | Dec 1, 2024 | 0.33 | — | — | — |
| Oct 31, 2024 | Sep 1, 2024 | 0.29 | 0.75 | +0.46 | +158.62% |
| Sep 5, 2024 | Jun 1, 2024 | 0.00 | 0.46 | — | — |
| May 2, 2024 | Mar 1, 2024 | 0.00 | 0.19 | — | — |
| Feb 8, 2024 | Dec 1, 2023 | 0.00 | 0.14 | — | — |
| Nov 2, 2023 | Sep 1, 2023 | 0.00 | -0.17 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | main | Buy | Buy |
| Sep 9, 2024 | Ascendiant Capital | main | Buy | Buy |
| Jan 4, 2017 | Ascendiant Capital | init | — | Buy |
About Pro-Dex, Inc.
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- pro-dex.com
News
- Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates
- Pro-Dex Q1 EPS $0.92 Beats $0.66 Estimate, Sales $20.560M Beat $20.400M Estimate
- ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?
- Pro-Dex (NASDAQ:PDEX) Stock Breaks Below Two Hundred Day Moving Average – What’s Next?
- 5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
- Best Momentum Stocks to Buy for September 18th
- New Strong Buy Stocks for September 18th
- Bank of New York Mellon Corp Invests $678,000 in Pro-Dex, Inc. $PDEX
- Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $74
- 12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on PDEX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CABILLOT RAYMOND E | Director | Stock Award(Grant) | Nov 19, 2024 | 361,846 |
| CHARLTON ALISHA K | Chief Financial Officer | Stock Award(Grant) | Nov 19, 2024 | 16,339 |
| DOMINGO ANGELITA REBAMONTAN | Director | Stock Award(Grant) | Nov 19, 2024 | 13,437 |
| FARRELL WILLIAM JAMES III | Director | Stock Award(Grant) | Nov 19, 2024 | 6,100 |
| HOVDA DAVID C | Director | Stock Award(Grant) | Nov 19, 2024 | 3,300 |
| PHILP KATRINA MARIE KRAMER | Director | Stock Award(Grant) | Nov 19, 2024 | 15,696 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.72% | 121,127 | 5.56M | Sep 29, 2024 |
| Punch & Associates Investment Management, Inc. | 2.09% | 68,000 | 3.12M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 1.93% | 63,036 | 2.89M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 1.73% | 56,345 | 2.59M | Sep 29, 2024 |
| Blackrock Inc. | 1.19% | 38,782 | 1.78M | Sep 29, 2024 |
| Northern Trust Corporation | 0.96% | 31,328 | 1.44M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.01% | 98,013 | 4.50M | Sep 29, 2024 |
| DFA U.S. Small Cap Series | 0.75% | 24,389 | 1.12M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 0.68% | 22,090 | 1.01M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.39% | 12,698 | 582.84K | Oct 30, 2024 |
| Northern Small Cap Core Fund | 0.29% | 9,343 | 428.84K | Sep 29, 2024 |
| DFA U.S. Core Equity 1 Portfolio | 0.24% | 7,945 | 364.68K | Jul 30, 2024 |